ArriVent BioPharma Inc. C...

18.38
-0.25 (-1.34%)
At close: Apr 16, 2025, 11:31 AM

ArriVent BioPharma Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
n/a n/a n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
n/a -74.59M -36.91M -8.7M
13.82M 5.26M n/a n/a
-80.49M -69.33M -36.91M -51.61M
-80.49M -69.33M -36.91M -51.61M
15.3M 9.71M 6.47M 2.26M
79M 64.88M 30.43M 6.43M
n/a n/a n/a n/a
94.31M 74.59M 36.91M 8.7M
n/a n/a n/a n/a
n/a n/a n/a -754K
n/a 74.59M 36.91M 8.7M
n/a n/a -36.91M -11.59M
31.47M 31.96M 33.49M 33.49M
31.47M 31.96M 33.49M 33.49M
-2.56 -2.17 -1.1 -1.54
-2.56 -2.17 -1.1 -1.54
n/a -74.59M -36.91M -51.61M
n/a -74.59M -36.91M -11.59M
n/a n/a 36.91M 11.59M